ClinConnect ClinConnect Logo
Search / Trial NCT06076187

Protein Digestion After Bariatric Surgery in Older Adults

Launched by UNIVERSITAIRE ZIEKENHUIZEN KU LEUVEN · Oct 6, 2023

Trial Information

Current as of July 21, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is studying how well older adults digest dietary protein, particularly looking at differences between those who have had weight loss surgery (bariatric surgery) and those who have not. The researchers want to find out how common a condition called sarcopenia, which is the loss of muscle mass and strength, is among these groups. They are particularly focused on older adults, aged 65 and above, to understand the factors that may influence their muscle health.

To participate in this trial, you need to be at least 65 years old and fall into one of three groups: you have had bariatric surgery within the last 1 to 10 years, or you have not had any weight loss surgery. Unfortunately, if you have serious health issues like advanced organ failure, certain cancers, or specific gastrointestinal conditions, you would not be eligible to join. If you take part, you can expect to share your health history and possibly undergo some tests to help researchers gather important information about muscle health in relation to protein digestion.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Signed informed consent
  • Group 1,2,3: Age 65 years or older
  • Group 4,5,6: Age 18 to 65 years
  • Group 1,2,4,5: Previous bariatric surgery for obesity 1 - 10 years ago
  • Group 3,6: No previous weight loss surgery
  • Exclusion Criteria:
  • Current diagnosis of cancer
  • Advanced organ failure, including chronic kidney disease Stage 5, liver cirrhosis Stage 3, intestinal failure, heart failure stage D, or chronic obstructive pulmonary disease stage 4.
  • Immobility
  • Neuromuscular degenerative conditions
  • Gastrointestinal conditions including coeliac disease, Crohn's disease, previous resection of the small intestine, gastroparesis
  • Unable to follow the procedures of the studies due to cognitive impairment such as diagnosed dementia.
  • Allergy/intolerance to milk, or soy or spirulina

About Universitaire Ziekenhuizen Ku Leuven

Universitaire Ziekenhuizen KU Leuven is a leading academic medical center in Belgium, renowned for its commitment to advancing healthcare through innovative research and clinical excellence. Affiliated with KU Leuven, one of Europe’s premier universities, the institution integrates cutting-edge scientific inquiry with high-quality patient care. It plays a pivotal role in the development and implementation of clinical trials, fostering collaboration between researchers, healthcare professionals, and industry partners to translate scientific discoveries into effective treatments. The hospital's multidisciplinary approach ensures comprehensive patient safety and ethical standards, positioning it as a trusted sponsor in the realm of clinical research.

Locations

Leuven, Vlaams Brabant, Belgium

Leuven, Flemish Brabant, Belgium

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported